1.上海中医药大学附属龙华医院肛肠科(上海 200032)
王佳雯,女,博士,主治医师,主要从事中医药防治肛肠疾病的临床研究工作
王琛,主任医师,硕士研究生导师;E-mail:wangchen_longhua@163.com
扫 描 看 全 文
王佳雯, 董若曦, 叶孙送, 等. 红萸饮联合切开拖线疗法治疗克罗恩病肛瘘的回顾性临床研究[J]. 上海中医药杂志, 2021,55(6):53-57.
Jiawen WANG, Ruoxi DONG, Sunsong YE, et al. A retrospective study on therapeutic effect of Hongyu Yin combined with cut and suture-dragging therapy for perianal fistulizing Crohn’s disease[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(6):53-57.
王佳雯, 董若曦, 叶孙送, 等. 红萸饮联合切开拖线疗法治疗克罗恩病肛瘘的回顾性临床研究[J]. 上海中医药杂志, 2021,55(6):53-57. DOI: 10.16305/j.1007-1334.2021.2104011.
Jiawen WANG, Ruoxi DONG, Sunsong YE, et al. A retrospective study on therapeutic effect of Hongyu Yin combined with cut and suture-dragging therapy for perianal fistulizing Crohn’s disease[J]. Shanghai Journal of Traditional Chinese Medicine, 2021,55(6):53-57. DOI: 10.16305/j.1007-1334.2021.2104011.
目的,2,回顾观察顾氏外科特色疗法红萸饮联合切开拖线疗法治疗克罗恩病肛瘘(pfCD)的临床疗效及安全性。,方法,2,回顾性分析2007年6月至2017年6月本院诊治的66例pfCD患者的临床资料,根据治疗方法分组,治疗组为采用中药红萸饮口服联合切开拖线疗法的患者,对照组为单纯采用切开拖线疗法的患者,其中治疗组35例,对照组31例。12周后,比较两组患者复发情况、愈合时间、中医证候疗效、肛周疾病活动指数(PDAI)总分及主要分项评分、克罗恩疾病活动指数(CDAI)总分及主要分项评分,同时进行安全性评价。,结果,2,①治疗组和对照组的性别、年龄、手术史、确诊年龄、肛瘘类型、病变部位等基线资料比较,差异无统计学意义(,P,>,0.05)。②治疗后,治疗组疾病复发情况与对照组比较,差异无统计学意义(,P,>,0.05);治疗组平均愈合时间、中医证候疗效明显优于对照组(,P,<,0.05)。③治疗后,两组的PDAI总分及主要分项评分较治疗前均有显著改善(,P,<,0.05),且治疗组评分均低于对照组(,P,<,0.05)。④治疗后,两组CDAI总分、腹痛评分、腹泻评分较治疗前均有显著改善(,P,<,0.05),且治疗组评分低于对照组(,P,<,0.05),但两组发热评分无明显差异(,P,>,0.05)。⑤两组不良反应发生率比较,差异无统计学意义(,P,>,0.05)。,结论,2,与单纯采用切开拖线疗法相比,加用红萸饮口服治疗pfCD疗效满意,可明显缩短pfCD的愈合时间,在缓解疾病症状、提高患者生活质量方面有其明显优势,且安全性良好。
Objective,2,To observe the clinical efficacy and safety of Gu’s traditional surgical treatment of Hongyu Yin combined with cut and suture-dragging therapy for the perianal fistulizing Crohn’s disease(pfCD).,Methods,2,The clinical data of 66 Crohn’s disease patients with perianal fistulizing diagnosed and treated in our hospital from June 2007 to June 2017 were retrospectively analyzed. According to the treatment methods, patients were divided into treatment group(35 cases) and control group(31 cases).The treatment group was treated with Hongyu Yin combined with cut and suture-dragging therapy, while the control group was treated with cut and suture-dragging therapy. After 12 weeks, the clinical recurrence rate, healing time, therapeutic effect of TCM syndrome, the total scores of perianal disease activity index(PDAI) and main sub-items scores, the total scores of Crohn’s disease activity index(CDAI) and main sub-items scores were comparatively analyzed, and safety was assessed simultaneously.,Results,2,①There was no statistically significant difference in baseline data between the treatment group and the control group in terms of gender, age, surgical history, age at diagnosis, type of anal fistula, and lesion location (,P,>,0.05).②After treatment, there was no significant difference in the recurrence rate in two groups(,P,>,0.05), and the average healing time and the therapeutic effect of TCM syndrome in the treatment group was significantly better than those in the control group(,P,<,0.05). ③After treatment, the total scores of PDAI and main sub-items scores in the two groups were decreased(,P,<,0.05), and the scores of the treatment group were lower than those of the control group (,P,<,0.05). ④After treatment, the total scores of CDAI, abdominal pain score, and diarrhea score of the two groups were significantly decreased(,P,<,0.05), and the scores of the treatment group were lower than those of the control group(,P,<,0.05), but there was no significant difference in fever score between the two groups(,P,>,0.05). ⑤There was no significant difference in the incidence of adverse reactions between the two groups(,P,>,0.05).,Conclusion,2,Compared with suture-dragging therapy alone, Hongyu Yin combined with suture-dragging therapy could achieve satisfactory results in treating with pfCD patients as it could significantly shorten the healing time, alleviate disease symptoms and improve the quality of life while having safety.
克罗恩病克罗恩病肛瘘切开拖线疗法红萸饮回顾性研究
Crohn’s diseaseperianal fistulizing Crohn’s diseasecut and suture-dragging therapyHongyu Yinretrospective study
叶子茵,肖书渊,李增山,等. 中国炎症性肠病病理诊断专家指导意见[J]. 中华炎性肠病杂志,2021, 5(1): 5-20.
SCHWARTZ D A, GHAZI L J, REGUEIRO M, et al. Guidelines for the multidisciplinary management of Crohn’s perianal fistulas: summary statement[J]. Inflamm Bowel Dis, 2015, 21(4): 723-730.
TORRES J, BONOVAS S, DOHERTY G, et al. ECCO Guidelines on therapeutics in Crohn’s disease: medical treatment[J]. J Crohns Colitis, 2020, 14(1): 4-22.
潘一滨. 红萸饮治疗溃疡性结肠炎的临床观察和实验研究[D]. 上海:上海中医药大学,2011.
中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志,2018, 38(9): 796-813.
KAMM M A, NG S C. Pefianal fistulizing Crohn’s disease: a call to action[J]. Clin Gastroenterol Hepatol, 2008, 6(1): 7-10.
WASMANN K A, DE GROOF E J, STELLINGWERF M E, et al. Treatment of perianal fistulas in Crohn’s Disease, seton versus anti-TNF versus surgical closure following anti-TNF (PISA): a randomised controlled trial[J]. J Crohns Colitis, 2020, 14(8): 1049-1056.
陆金根,曹永清,姚一博. 肛瘘拖线疗法临床实践指南(2019)[J]. 结直肠肛门外科,2020, 26(1): 1-4.
国家药品监督管理局. 中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社,2002.
SCIAUDONE G, DI STAZIO C, LIMONGELLI P, et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach[J]. Can J Surg, 2010, 53(5): 299-304.
杨柏霖,竺平,孙桂东. 克罗恩肛瘘的诊断与治疗[C]//中国中西医结合学会. 第十三届全国中西医结合大肠肛门病学术会议暨第三届国际结直肠外科论坛论文汇编.天津:中国中西医结合学会工作组,2009: 5.
董四海,汤翔,朱文,等. 分期从痈论治肛周克罗恩病36例[J]. 湖南中医杂志,2009, 25(5): 72-73.
李志雄. 克罗恩病的中医古籍文献整理[D]. 广州:广州中医药大学,2016.
张馨心,周唯,陆金根,等. 基于网络药理学探讨红萸饮治疗溃疡性结肠炎的分子机制[J]. 世界中医药,2021, 16(6): 52-62.
WANG J W, PAN Y B, CAO Y Q, et al. Salidroside regulates the expressions of IL-6 and defensins in LPS-activated intestinal epithelial cells through NF-κB/MAPK and STAT3 pathways[J]. Iran J Basic Med Sci, 2019, 22(1): 31-37.
WANG J W, PAN Y B, CAO Y Q,et al. Loganin alleviates LPS-activated intestinal epithelial inflammation by regulating TLR4/NF-κB and JAK/STAT3 signaling pathways[J]. Kaohsiung J Med Sci, 2020, 36(4): 257-264.
张昊悦,王业皇,吴燕兰. 克罗恩肛瘘发病机制的研究进展[J]. 广西医学,2019, 41(24): 3193-3197.
罗泽昊,彭云花,陆宏,等. 克罗恩病肛瘘的中西医治疗进展[J]. 结直肠肛门外科,2020, 26(4): 511-515.
0
浏览量
326
下载量
0
CSCD
6
CNKI被引量
关联资源
相关文章
相关作者
相关机构